KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) EPS (Basic) Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.80%
Dec 31, 2025 16.23%
Sep 30, 2025 5.41%
Jun 30, 2025 78.26%
Mar 31, 2025 40.93%
Dec 31, 2024 15.69%
Sep 30, 2024 -6.28%
Jun 30, 2024 -1.16%
Mar 31, 2024 -50.06%
Dec 31, 2023 4.15%
Sep 30, 2023 -4.12%
Jun 30, 2023 33.90%
Mar 31, 2023 3.48%
Dec 31, 2022 21.76%
Sep 30, 2022 7.60%
Jun 30, 2022 3.65%
Mar 31, 2022 -8.78%
Dec 31, 2021 15.09%
Sep 30, 2021 -0.56%
Jun 30, 2021 -7.66%
Mar 31, 2021 4.56%
Dec 31, 2020 -105.99%
Sep 30, 2020 14.60%
Jun 30, 2020 12.94%
Mar 31, 2020 -19.91%
Dec 31, 2019 -124.48%
Sep 30, 2019 14.06%
Jun 30, 2019 34.49%
Mar 31, 2019 13.00%
Dec 31, 2018 10.04%
Sep 30, 2018 22.53%
Jun 30, 2018 -6.97%
Mar 31, 2018 19.72%
Dec 31, 2017 -35.31%
Sep 30, 2017 26.26%
Jun 30, 2017 8.06%
Mar 31, 2017 7.89%
Dec 31, 2016 1.17%
Sep 30, 2016 4.78%
Jun 30, 2016 5.72%
Mar 31, 2016 4.42%
Dec 31, 2015 -19.42%
Sep 30, 2015 -5.25%
Jun 30, 2015 -16.52%
Mar 31, 2015 10.55%
Dec 31, 2014 -50.31%
Sep 30, 2014 -2.58%
Jun 30, 2014 -14.59%
Mar 31, 2014 11.55%